Kidney Biomarkers and Acute Kidney Injury After Chemotherapy
Author Information
Author(s): Chen Chao-Yu, Wang Ting-Yao, Chang Hung-Yu, Chen Min-Chi, Yang Lan-Yan
Primary Institution: Chang Gung Memorial Hospital, Chiayi, Taiwan
Hypothesis
Can kidney-specific biomarkers accurately predict acute kidney injury after cytoreduction and hyperthermic intraperitoneal chemotherapy?
Conclusion
The study found that variations in kidney-specific biomarkers may help predict acute kidney injury, but absolute measurements alone are not sufficient.
Supporting Evidence
- 5 out of 75 patients developed acute kidney injury during the study.
- Significant differences in biomarker levels were observed on specific days post-surgery.
- The study was conducted over a period from January 2018 to December 2020.
Takeaway
Doctors are trying to find better ways to tell if kidneys are hurt after surgery and chemotherapy, and some special tests might help.
Methodology
This was a prospective observational study where urine and serum samples were collected from patients undergoing CRS/HIPEC to measure kidney-specific biomarkers.
Potential Biases
Potential bias due to the observational nature of the study and the lack of blinding.
Limitations
The study had a small sample size and a low number of acute kidney injury cases, which may limit the generalizability of the findings.
Participant Demographics
Median age was 60 years, with a mix of cancer types including gastric, ovarian, and colorectal cancers.
Statistical Information
P-Value
0.025
Confidence Interval
95% CI, 0.73–0.76
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website